This review will provide a comprehensive overview of the IL-5 signalling pathway and its relationship to asthma, whilst the second part of this review will focus on the three monoclonal antibody therapies currently approved or undergoing trials, providing a critical analysis and comparison between the three. The gene discussed is IL5; the disease is asthma.